Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene.
Sarcoidosis vasculitis and diffuse lung diseases · 30.09.2026 · 43 (3) · 19046-19046
DOI: 10.36141/svdld.2026.19046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 30.09.2026. Verfasst von Min Kyung Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interdisciplinary Program in Biomedical Science Major, Graduate School, Soonchunhyang University, Asan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with poor prognosis. Lung fibroblasts isolated from patients with IPF exhibit enhanced proliferative capacity; however, the molecular determinants linking fibroblast proliferation to clinical outcomes remain incompletely understood. METHODS: Fibroblast growth slopes were measured in primary lung fibroblast derived from patients with IPF and control subjects. Transcriptome microarray data were integrated with fibroblast growth kinetics to identify growth slope-associated genes. Differential expression analysis was performed between IPF and control fibroblasts, and candidate genes were further evaluated at the mRNA and protein levels in lung fibroblasts and bronchoalveolar lavage (BAL) fluids. Associations with clinical outcomes were assessed. RESULTS: Fibroblasts derived from patients with IPF showed significantly higher growth slope than control fibroblasts, and increased fibroblast growth slope were associated with reduced survival in IPF. Integration of fibroblast growth kinetics with transcriptomic analysis identified a fibroblast growth slope-associated gene signature, from which PITX1 emerged as a disease-relevant candidate gene. PITX1 mRNA and protein levels were elevated in IPF fibroblasts compared with controls. In BAL fluids, PITX1 protein levels were significantly higher in patients with IPF and were associated with clinical outcomes, although they did not correlate with pulmonary function parameters. CONCLUSIONS: Enhanced fibroblast proliferative capacity is associated with poor prognosis in IPF, and PITX1 represents a fibroblast growth slope-associated gene reflecting fibroblast heterogeneity and prognostic relevance. These findings suggest that assessment of fibroblast growth behavior and PITX1 expression may provide insight into disease progression in IPF, although further validation studies are required.
Schlagwörter
Autor:innen und Institutionen
- Department of Interdisciplinary Program in Biomedical Science Major, Graduate School, Soonchunhyang University, Asan.
- Division of Allergy and Respiratory Medicine, Dept. of Internal Medicine, Soonchunhyang University Bucheon Hospital.
- Department of Internal Medicine, Soonchunhyang University Bucheon Hospital.
Zitieren
APA
Kim, M. K., Park, S. L., Seo, E. J., Kim, S. Y., Park, S. W., & Lee, J. U. (2026). Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene. Sarcoidosis vasculitis and diffuse lung diseases, 43(3), 19046-19046. https://doi.org/10.36141/svdld.2026.19046
Vancouver
Kim MK, Park SL, Seo EJ, Kim SY, Park SW, Lee JU. Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(3):19046-19046. doi:10.36141/svdld.2026.19046
BibTeX
@article{Kim2026,
author = {Kim, Min Kyung and Park, Seung-Lee and Seo, Eun Jeong and Kim, So-Yoon and Park, Sung Woo and Lee, Jong-Uk},
title = {Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene},
journal = {Sarcoidosis vasculitis and diffuse lung diseases},
year = {2026},
volume = {43},
number = {3},
pages = {19046--19046},
doi = {10.36141/svdld.2026.19046}
}
EUVIMED